Clinical, ultrasonographic, computed tomography and histopathological manifestations of ovarian steroid cell tumour, not otherwise specified: our experience of a rare case with female virilisation and review of the literature

References

• Stylianidou A, Varras M, Akrivis C, Fylaktidou A, Stefanaki S, Antoniou N. Sclerosing stromal tumor of the ovary: a case report and review of the literature. Eur J Gynaecol Oncol 2001;22:300–304.
   Google Scholar
• Cserepes E, Szücs N, Patkó Z, Molnár F, Tóth M, Dabasi G, Esik O, Rácz K. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperadrogenism. Gynecol Endocrinol 2002;16:213–216.
   PubMed Web of Science ®Google Scholar
• Antoniou N, Varras M, Akrivis Ch, Demou A, Bellou A, Stefanaki S. Mucinous cystadenoma of the ovary with functioning stroma and virilization in pregnancy: a case report and review of the literature. Clin Exp Obstet Gynecol 2003;30:248–252.
   PubMedGoogle Scholar
• Tanaka YO, Tsunoda H, Kitagawa Y, Ueno T, Yoshikawa H, Saida Y. Functioning ovarian tumors: direct and indirect findings at MRI. RadioGraphics 2004;24:S147–S166.
   Web of Science ®Google Scholar
• Kim YT, Kim SW, Yoon BS, KIm SH, Kim JW, Cho NH. An ovarian steroid cell tumor causing virilization and massive ascites. Yonsei Med J 2007;48:142–146.
   PubMed Web of Science ®Google Scholar
• Hartman LC, Young RH, Evans MP, Podratz KC. In: Hoskins WJ, Perez CA, Young RC, editors. Principles and practice of gynecologic oncology. 2nd ed. Philadelphia: Lippincott-Raven; 1997. pp 1015–1019.
   Google Scholar
• Reedy MB, Richards WE, Ueland F, Uy K, Lee EY, Bryant C, van Nagel JR Jr. Ovarian steroid cell tumors, not otherwise specified: a case report and literature review. Gynecol Oncol 1999;75:293–297.
   PubMedGoogle Scholar
• Vassilakaki Th, Grammatoglou X, Savvaidou V, Skafida E, Glava Ch, Delliou E. Ovarian steroid cell tumor: a case report and literature review. Epistimonika Chronika 2009;1:29–31 (in Greek).
   Google Scholar
• Scully RE. Tumors of the ovary and maldevelopment gonads. In: Hartmann WH, editor. Atlas of tumor pathology, fasc 16, ser 2. Washington, D.C.: Armed Forces Institute of Pathology, 1979.
   Google Scholar
• Young RH, Scully RE. Sex cord-stromal, steroid cell and other ovarian tumors. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. 5th ed. Springer; 2001. p 905.
   Google Scholar
• Mohanty A, Trujillo YP. Virilization and left adnexal mass in a 35-year-old woman. Arch Pathol Lab Med 2006;130:113–114.
   PubMedGoogle Scholar
• Outwater EK, Wagner BJ, Mannion C, McLarney JK, Kim B. Sex cord-stromal and steroid cell tumors of the ovary. RadioGraphics 1998;18:1523–1546.
   PubMed Web of Science ®Google Scholar
• Mok J-E, Sohn W-S. Surgical management of steroid cell tumors of the ovary. CME J Obstet Oncol 2003;8:173–178.
   Google Scholar
• Eladd TA, Connolly V, Cruickshank D, Kelly WF. An ovarian lipid cell tumour causing virilization and Cushing's syndrome. Clin Endocrinol (Oxf) 1996;44:723–725.
   Google Scholar
• Hayes MC, Scully RE. Ovarian steroid cell tumors (not otherwise specified): a clinicopathological analysis of 63 cases. Am J Surg Pathol 1987;11:835–845.
   PubMed Web of Science ®Google Scholar
• Taylor HB, Norris HJ. Lipoid cell tumor of the ovary. Cancer 1976;20:1953–1962.
   Google Scholar
• Luk WT, Lee N, Cang TC, Chu KK. Lipid cell tumor of the ovary associated with endometrial adenocarcinoma – a case report. Chang Keng Hsueh 1989;12:244–248.
   PubMedGoogle Scholar
• Donovan JT, Otis CN, Powell JL, Cathcart HK. Cushing's syndrome secondary to malignant lipoid cell tumor of the ovary. Obstet Oncol 1993;50:249–253.
   Google Scholar
• Anderson PW, D'Abling III G, Penny R, Sherrod A, Do YS. Secretion of prorenin by virilizing ovarian tumor. Gynecol Oncol 1992;45:58–61.
   PubMed Web of Science ®Google Scholar
• Monteagudo A, Heller D, Husami N, Levine RU, McCaffrey R, Timor-Tritsch IE. Ovarian steroid cell tumors: sonographic characteristics. Ultrasound Obstet Gynecol 1997;10:282–288.
   PubMed Web of Science ®Google Scholar
• Wang PH, Chao HT, Lee RC, Lai CR, Lee WL, Kwok CF, Yuan CC, Ng HT. Steroid cell tumors of the ovary: clinical, ultrasonic, and MRI diagnosis – a case report. Eur J Radiol 1998; 26:269–273.
   PubMed Web of Science ®Google Scholar
• Haji AG, Sharma S, Babu M, Vijaykumar DK, Chitrathara K. Androgen secreting steroid cell tumor of the ovary in a young lactating woman with acute onset of severe hyperandrogenism: a case report and review of the literature. J Med Case Rep 2007;1: 182, (doi: 10.1186/1752–1947–1–182).
   Google Scholar
• Outwater EK, Marchetto B, Wagner BJ. Virilizing tumors of the ovary: imaging features. Ultrasound Obstet Gynecol 2000;15:365–371.
   PubMed Web of Science ®Google Scholar
• Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275–288.
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis. Adv Cancer Res 1985;43:175–200.
   PubMed Web of Science ®Google Scholar
• Saida T, Tanaka YO, Minami M. Steroid cell tumor of the ovary, not otherwise specified: CT and MR findings. AJR Am J Roentgenol 2007;8:W393–W394.
   Google Scholar
• Rishi M, Howard LN, Bratthauer GL, et al Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumor of the ovary. Am J Surg Pathol 1997;21:583–589.
   PubMed Web of Science ®Google Scholar
• Kommos F, Oliva E, Bhan AK, Young RH, Scully RE. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol 1998;11:656–664.
   Google Scholar
• Deavers MT, Malpica A, Ordonez NG, Silva EG. Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin. Int J Gynecol Pathol 2003;22:162–167.
   PubMedGoogle Scholar
• Clement PB, Young RH. Atlas of gynecologic surgical pathology. Philadelphia, PA: W.B. Saunders Co; 2000.
   Google Scholar
• Barakat RR, Rubin SC, Wong G. Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases. Obstet Gynecol 1992;80:660–664.
   PubMed Web of Science ®Google Scholar
• Pascale MM, Pugeat M, Roberts M. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumors. Clin Endocrinol (Oxf.) 1994;41:571–576.
   PubMed Web of Science ®Google Scholar
• Brewer CA, Shevlin D. Encouraging response of an advanced steroid-cell tumor to GnRH agonist therapy. Obstet Gynecol 1998;92:661–663.
   Google Scholar
• Schwartz PE, Price FV, Synder MK. Management of ovarian stromal tumors. In: Rubin SC, Sutton GP, editors. Ovarian cancer. 2nd ed. Lipincott Williams and Wilkins; 2001. p 383.
   Google Scholar
• Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer CA, Saul PB, Wharton JT. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin and cyclophosphamide. Obstet Gynecol 1987;70:765.
   PubMedGoogle Scholar
• Gershenson DM. Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol Oncol 1994;55:S62.
   PubMed Web of Science ®Google Scholar
• Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide and cisplatin. Obstet Gynecol 1996;87:527.
   PubMedGoogle Scholar
• Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group Study. Gynecol Oncol 1999;72:131.
   PubMed Web of Science ®Google Scholar
• Powell JL, Dulancy DP, Shiro BC. Androgen-secreting steroid cell tumor of the ovary. South Med J 2000;93:1201.
   Google Scholar